Iran Peace Deal Could Open Strait of Hormuz Without Conditions Petraeus Suggests Genpact CEO Warns AI Could Reduce IT Workload and Job Growth in India US AI Titans DeepSeek Fears May Be Overstated Mining Sector Faces Headwinds and Opportunities in Energy Transition Report Suggests Japans Megabanks Post Record Profits But Analysts Flag Headwinds Ahead Federal Reserve Faces Challenges in Justifying Rate Cuts as Cost of Living Pressures Intensify CarPartscom PRTS Q1 2026 Earnings EPS Beat Despite Challenging Environment SCHL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Response VIOT Q4 2022 Earnings WiderThanExpected Loss Reported Shares Rally 444 PDF Solutions Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction JUNS Q4 2025 Earnings NarrowerThanExpected Loss Reflects Cost Control Efforts Despite No Revenue BWB Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower Concorde International Group Ltd CIGL Holds Steady at 199 as Consolidation Continues Taiwan Fund Inc TWN Edges Higher Amid Support Resistance Levels in Focus Hudson Technologies HDSN Slides 21 as Key Support Level Approaches Equity Residential EQR Holds Steady Near Key Support as Real Estate Sector Faces Crosscurrents Mohawk Industries MHK Edges Higher Amid Stabilizing Flooring Demand Post Office Horizon Inquiry Faces FiveYear Delay Without Urgent Funding and Staff Increase USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh BingEx FLX Shares Edge Higher Testing Resistance Zone Okta Could Raise Fiscal 2027 Guidance Amid Improved Demand and Execution Barclays Suggests HFBL Q3 2025 Earnings EPS of 024 Amid a Challenging Rate Environment LBRDA Q3 2025 Earnings Strong EPS Beat Boosts Investor Sentiment AI Biotech Firm Secures 104 Million Investment from Nvidia JP Morgan CEOs Cockroach Warning Gives Way to Credit Termites in Opaque AI Loan Markets UK Chancellor Reeves Proposes VAT Cut on Summer Attractions to 5 Amid CostofLiving Relief Package MNOV Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances